VXRT vs XYL · rev $66.4M vs P/E 27, rev $4.46B
Vaxart Inc (VXRT) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported VXRT revenue for 2026-06-30 was $66.4M. Net income was -$8.3M. Revenue was up 69.3% from 2026-03-31 to 2026-06-30. VXRT currently screens at market cap $73.0M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
VXRT currently screens at market cap $73.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the VXRT and XYL stock pages for the full models.
Not investment advice.